Patent details

EP2468271 Title: Pharmaceutical composition comprising droxidopa for the treatment of fibromyalgia

Basic Information

Publication number:
EP2468271
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP121501076
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Pharmaceutical composition comprising droxidopa for the treatment of fibromyalgia
French Title of Invention:
Composition pharmaceutique à base de droxidopa pour le traitement de la fibromyalgie
German Title of Invention:
Pharmazeutische Zusammensetzung enthaltend Droxidopa zur Behandlung von Fibromyalgie
SPC Number:

Dates

Filing date:
07/03/2008
Grant date:
16/07/2014
EP Publication Date:
16/07/2014
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
27/06/2012
EP B1 Publication Date:
16/07/2014
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
07/03/2015
Expiration date:
07/03/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
07/03/2008
 
 

Name:
Chelsea Therapeutics Inc.
Address:
3530 Toringdon Way Suite 200, Charlotte, NC 28277, United States (US)

Inventor

1

Name:
Pedder Simon
Address:
United States (US)

2

Name:
Roberts Michael J.
Address:
United States (US)

Priority

Priority Number:
894030 P
Priority Date:
09/03/2007
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/195;
Filing date Document type Number of pages